Pulse.

a daily field guide to health research that matters

◆ Console

‹ Tue · 10 Nov 2026
Promising but preliminary

Single-cell profiling reveals GABBR1 as a cuproptosis-regulated prognostic biomarker in pancreatic cancer.

Understanding a specific gene's role in pancreatic cancer opens new possibilities for targeting treatment sensitivity.

We performed integrated analyses of scRNA-seq data from patients with PC (GSE212966) and The Cancer Genome Atlas-pancreatic adenocarcinoma dataset. Modulating GABBR1 can reshape cuproptosis pathways, thereby influencing apoptotic sensitivity and modulating immune responses.

What the study was

Study design
Validation study
Category
Genomics/Precision Medicine
Maturity
Validated
Journal
iLIVER

Why it surfaced

⚪ PROMISING_PRELIMINARY — Promising but preliminary; Watchlist: Precision oncology and genomic medicine; Design: Validation study; species: unknown

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.